DC Funds’s Barinthus Biotherapeutics BRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $597K | Hold |
642,204
| – | – | 27.74% | 3 |
|
|
2025
Q1 | $625K | Hold |
642,204
| – | – | 30.22% | 2 |
|
|
2024
Q4 | $776K | Hold |
642,204
| – | – | 21.77% | 3 |
|
|
2024
Q3 | $764K | Hold |
642,204
| – | – | 14.84% | 3 |
|
|
2024
Q2 | $899K | Hold |
642,204
| – | – | 14.93% | 3 |
|
|
2024
Q1 | $1.53M | Hold |
642,204
| – | – | 14.77% | 3 |
|
|
2023
Q4 | $2.37M | Hold |
642,204
| – | – | 28.49% | 2 |
|
|
2023
Q3 | $1.98M | Hold |
642,204
| – | – | 40.85% | 1 |
|
|
2023
Q2 | $1.32M | Hold |
642,204
| – | – | 28.18% | 3 |
|
|
2023
Q1 | $1.44M | Hold |
642,204
| – | – | 33.51% | 2 |
|
|
2022
Q4 | $1.51M | Hold |
642,204
| – | – | 40.86% | 1 |
|
|
2022
Q3 | $2.06M | Hold |
642,204
| – | – | 30.98% | 2 |
|
|
2022
Q2 | $2.86M | Hold |
642,204
| – | – | 39.43% | 1 |
|
|
2022
Q1 | $3.34M | Hold |
642,204
| – | – | 43.39% | 1 |
|
|
2021
Q4 | $7.14M | Hold |
642,204
| – | – | 42.25% | 1 |
|
|
2021
Q3 | $10.1M | Hold |
642,204
| – | – | 39.68% | 2 |
|
|
2021
Q2 | $10.8M | Buy |
+642,204
| New | +$10.8M | 51.19% | 1 |
|